SNTI
SNTI
NASDAQ · Biotechnology

Senti Biosciences Inc

$1.10
-0.01 (-0.90%)
As of Jun 30, 10:47 PM ET ·
Financial Highlights (FY 2026)
Revenue
31.1K
Net Income
-85,106,160
Gross Margin
Profit Margin
-279,263.6%
Rev Growth
-82.8%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 52.7% 52.7%
Operating Margin -312,631.8% -281,370.1% 7.9% 7.6%
Profit Margin -279,263.6% -265,300.5% 8.0% 5.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 31.1K 180.5K 15.18M 16.45M
Gross Profit 8.01M 8.68M
Operating Income -97,366,054 -507,996,803 1.19M 1.25M
Net Income -85,106,160 -444,032,139 1.21M 962.0K
Gross Margin 52.7% 52.7%
Operating Margin -312,631.8% -281,370.1% 7.9% 7.6%
Profit Margin -279,263.6% -265,300.5% 8.0% 5.9%
Rev Growth -82.8% -82.8% +1.7% +13.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 3.21M 3.14M
Total Equity 9.87M 10.49M
D/E Ratio 0.33 0.30
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -91,487,720 -503,845,414 1.98M 2.22M
Free Cash Flow 1.07M 1.04M